Long Non-coding RNA CASC2 Enhances the Antitumor Activity of Cisplatin Through Suppressing the Akt Pathway by Inhibition of miR-181a in Esophageal Squamous Cell Carcinoma Cells

Background: Long non-coding RNA CASC2 (lncRNA CASC2) has been found to be down-regulated in esophageal squamous cell carcinoma (ESCC). However, the effect of CASC2 on cisplatin-treated ESCC was unclear. The present study aimed to evaluate the role of CASC2 in cisplatin-treated ESCC cells. Methods: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Dengyan, Yu, Yang, Qi, Yu, Wu, Kai, Liu, Donglei, Yang, Yang, Zhang, Chunyang, Zhao, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514198/
https://www.ncbi.nlm.nih.gov/pubmed/31134151
http://dx.doi.org/10.3389/fonc.2019.00350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514198/
https://www.ncbi.nlm.nih.gov/pubmed/31134151
http://dx.doi.org/10.3389/fonc.2019.00350

Ejemplares similares